Evidence map›Paper›PMID 41889590›Full record

ArticleUrology case reports2026

Bladder sarcomatoid carcinoma and giant cell carcinoma without recurrence after robot-assisted radical cystectomy: A case report.

Tomoki Taniguchi, Masayuki Tomioka, Kota Kawase, Koji Iinuma, Yuki Tobisawa, Keita Nakane, Kosuke Mori, Tatsuhiko Miyazaki, Takuya Koie

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Urology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tomoki TaniguchiDepartment of Urology, Graduate School of Medicine, Gifu University, Japan.
Masayuki TomiokaDepartment of Urology, Graduate School of Medicine, Gifu University, Japan.
Kota KawaseDepartment of Urology, Graduate School of Medicine, Gifu University, Japan.
Koji IinumaDepartment of Urology, Graduate School of Medicine, Gifu University, Japan.
Yuki TobisawaDepartment of Urology, Graduate School of Medicine, Gifu University, Japan.
Keita NakaneDepartment of Urology, Graduate School of Medicine, Gifu University, Japan.
Kosuke MoriDepartment of Pathology, Graduate School of Medicine, Gifu University, Japan.
Tatsuhiko MiyazakiDepartment of Pathology, Graduate School of Medicine, Gifu University, Japan.
Takuya KoieDepartment of Urology, Graduate School of Medicine, Gifu University, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bladder sarcomatoid carcinoma is a rare, aggressive tumor with epithelial and mesenchymal features. We report a 69-year-old man with muscle-invasive bladder neck urothelial carcinoma with giant cell subtype. After two cycles of gemcitabine and cisplatin, imaging revealed tumor shrinkage. Robot-assisted radical cystectomy with pelvic lymphadenectomy and intracorporeal ileal conduit was performed. Pathology confirmed sarcomatoid carcinoma with lymphovascular invasion but negative margins. The urothelial component responded to chemotherapy, whereas the sarcomatoid component did not. No recurrence was observed for 18 months follow-up. Prompt chemotherapy and robotic surgery achieved a favorable outcome in this rare bladder cancer.

Indexed as

Bladder cancerGiant cell subtypeNeoadjuvant chemotherapyRobot-assisted radical cystectomySarcomatoid carcinoma

Identifiers

PMID41889590
PMCPMC13014636

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.